U.S. federal trademark · Serial No. 85177602
A protein agent termed leukotoxin derived from a bacterium used in the manufacture of anti-cancer drugs that has specificity for white blood cells
Pharmaceutical preparations for the treatment of white blood cell diseases in the form of protein agent termed leukotoxin derived from a bacterium that has specificity for white blood cells
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.